Regular therapy for malignant glioma (MG) does not specifically remove tumor cells, leading to toxicity that limits therapeutic efficacy. individual mAbs via phage screen technology completely, transgenic mouse systems and, recently, mRNA and ribosome screen,13, 14 significantly reducing the chance of immunogenicity against the medication and increasing scientific safety. Problems connected with murine antibodies found… Continue reading Regular therapy for malignant glioma (MG) does not specifically remove tumor
Category: p53
AIM: To determine a convenient immunoassay technique predicated on recombinant antigen
AIM: To determine a convenient immunoassay technique predicated on recombinant antigen preS1(21-119 aa) to detect anti-preS1 antibodies and measure the clinical need for antibodies in hepatitis B. plasmid family pet-28a-preS1 within a soluble type in (30 mg?L?1), and easily purified to high purity more than 90% by one stage of Ni2+-IDA-sepharose 6B affinity chromatography. The… Continue reading AIM: To determine a convenient immunoassay technique predicated on recombinant antigen